Procalcitonin Test for Differentiation of the Cause of Pneumonia
NCT03350802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 649
Last updated 2020-09-25
Summary
The purpose of this study is to evaluate the usefulness of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
procalcitonin test
All patients enrolled in this cohort undergo procalcitonin test in addition to basic microbiological test.
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
HEE SEOK LEE, M.D. · National Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
NCT03073902 ·Status: COMPLETED
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
NCT06503042 ·Status: NOT_YET_RECRUITING
-
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
NCT06733311 ·Status: RECRUITING
-
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
NCT03804255 ·Status: WITHDRAWN
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077 ·Status: RECRUITING
-
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
NCT06833229 ·Status: RECRUITING
-
The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer
NCT05164445 ·Status: COMPLETED ·Phase: NA
-
Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer
NCT05928299 ·Status: COMPLETED
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Detection of Early Lung Cancer by Serum Protein Expression Profiling
NCT00175578 ·Status: UNKNOWN
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
NCT02726633 ·Status: UNKNOWN
-
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).
NCT05602259 ·Status: RECRUITING ·Phase: NA
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Korean Lung Cancer Screening Project
NCT03394703 ·Status: UNKNOWN
-
SLN Detection With Tc-MSA-ICG in Lung Cancer Patients
NCT05039905 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
NCT05985330 ·Status: RECRUITING
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients
NCT04203095 ·Status: UNKNOWN
-
Cancer Panel From Blood of Lung Cancer Patients
NCT03235765 ·Status: UNKNOWN
-
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 ·Status: COMPLETED
-
Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer
NCT06301295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA